MRI firm Caprius posted a sharply lower net loss for its first quarter (end-December) this year than last, thanks in part to a $1.1 million payment to settle MRI patent litigation. The Wilmington, MA, company is still low on cash, however, and must find
MRI firm Caprius posted a sharply lower net loss for its first quarter (end-December) this year than last, thanks in part to a $1.1 million payment to settle MRI patent litigation. The Wilmington, MA, company is still low on cash, however, and must find a buyer for its Aurora MR mammography program in order to continue operations.
For the quarter, Caprius posted revenues from patient services of $1.1 million, compared with $842,000 in the same period a year ago. The company did not record any Aurora sales in the quarter. In fact, the firm lacks cash to manufacture more Aurora units or conduct further R&D, according to the vendors Securities and Exchange Commission 10-Q filing.
Caprius reported a net loss for the quarter of $199,000, down sharply from the $8.7 million loss reported in the first quarter of 1998. Much of the loss for the prior quarter was due to a $7.2 million charge for purchased R&D related to the 1997 merger between the companies that formed Caprius, Advanced NMR and Advanced Mammography Systems. In the most recent quarter, Caprius netted $1.1 million to settle payment claims related to Aurora from an unnamed MRI manufacturer.
Despite the lower net loss, Caprius will remain in dire straits if it doesnt find a buyer for the Aurora program. A proposed deal with venture capital firm Mi3 fell through in December (SCAN 1/13/99) and since then Caprius has been looking for other potential partners. Caprius had $1.5 million in cash as of Dec. 31, but the companys situation has prompted its auditor to issue a going concern statement, casting doubt on its future viability if Aurora isnt divested.
Study: AI Bolsters Sensitivity for Pneumothorax on CXR and Significantly Reduces Reporting Time
October 30th 2024For clinically actionable pneumothorax, an artificial intelligence algorithm demonstrated a 93 percent AUC and a 96 percent specificity rate in a study involving chest X-rays from over 27,000 adults.
Artifact Reduction Drives Technology Advances with Updated Version of Echelon Synergy MRI System
October 30th 2024Emerging technologies included with the 10th version of the 1.5T MRI platform include Synergy DLR Clear and Synergy Vision that are geared toward mitigating common challenges with artifacts.